Insider Purchases: Inside the Buy

Tag: MarkBertolini

Illustration of a hospital patient monitor displaying a rising stock chart while a doctor injects a syringe labeled $11.9M, symbolizing Oscar Health’s turnaround driven by CEO insider buying and tech-driven healthcare innovation.

April 8, 2026

CEO Bets $11.9M: Is Oscar Health (OSCR) About to Shock the Market? 🚀

Oscar Health (OSCR) is no longer just a flashy disruptor—it’s aiming for profitability. With CEO Mark Bertolini buying $11.9M in stock and revenue projected to hit $19B in 2026, this could be one of the most compelling turnaround plays in healthcare.

Read entire article

Tags: ACA, ACA market, buy or sell OSCR, CEO confidence, CEO purchases, disruptive insurance, featured-insiders, fintech healthcare, FUNanc1al, Funanc1al Investing, growth stocks, health insurance stocks, healthcare tech, HealthInsuranceStocks, hub-insiders, insider buying, InsiderBuying, Investing2026, Mark Bertolini, MarkBertolini, multibagger stocks, Oscar Health, OscarHealth, OSCR, OSCR stock, risks buying OSCR, short squeeze stocks, turnaround stocks, undervalued stocks, why buy OSCR

Your cart

Insider Purchases: Inside the Buy

Tag: MarkBertolini

April 8, 2026

CEO Bets $11.9M: Is Oscar Health (OSCR) About to Shock the Market? 🚀

Quick links

Contact us

About us

Follow us